Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ETHK LabsHKSE:01931 -1.69%74 Days Inventory is 387.16 as of Dec. 2025, which is 284% above its 10-year median of 100.71. GuruFocus rates HKSE:01931 with a GF Score™ of 74/100 and a GF Value™ of HK$1.38 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 116 Medical Distribution companies, ETHK Labs ranks worse than 99.14% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). ETHK Labs's Average Total Inventories for the
six
months ended in Dec. 2025 was HK$2,963 Mil. ETHK Labs's Cost of Goods Sold for the
six
months ended in Dec. 2025 was HK$1,397 Mil.
Hence, ETHK Labs's Days Inventory for the
six
months ended in Dec. 2025 was 387.16.
The historical rank and industry rank for ETHK Labs's Days Inventory or its related term are showing as below:
HKSE:01931'
s Days Inventory Range Over the Past 10 Years
Min: 62.26 Med: 100.71 Max: 355.67
Current: 355.67
During the past 10 years, ETHK Labs's highest Days Inventory was 355.67. The lowest was 62.26. And the median was 100.71.
HKSE:01931's Days Inventory is ranked worse than 99.14% of 116
companies
in the Medical Distribution industry
Industry Median: 57.495
vs HKSE:01931: 355.67
ETHK Labs's Days Inventory
increased
from Dec. 2024 (171.77) to Dec. 2025 (387.16).
It might indicate that ETHK Labs's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
ETHK Labs's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.47.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
ETHK Labs's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 1.73.
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
ETHK Labs's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
ETHK Labs's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
ETHK Labs Days Inventory Related Terms
ETHK Labs Days Inventory Historical Data
* Premium members only.
The historical data trend for ETHK Labs's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01931 vs MCK, COR, CAH: Days Inventory Comparison
For the Medical Distribution subindustry, ETHK Labs's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ETHK Labs Days Inventory vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, ETHK Labs's Days Inventory distribution charts can be found below:
* The bar in red indicates where ETHK Labs's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ETHK Labs (HKSE:01931) has a Days Inventory of 387.16 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on ETHK Labs and its competitors. This is 284% above median its historical median of 100.71. Over the past decade, ETHK Labs' Days Inventory has ranged from 62.26 to 355.67. According to the industry distribution chart, ETHK Labs ranks #115 out of 116 companies in the Medical Distribution industry, placing it in the top 99.1%.
Is ETHK Labs' Days Inventory too high?
ETHK Labs' current Days Inventory of 387.16 is 284% above median its 10-year median of 100.71. Over the past 10 years, this metric has ranged from a low of 62.26 to a high of 355.67. The Medical Distribution industry median Days Inventory is 57.50. ETHK Labs' value of 387.16 is 573.4% above this industry median. Based on the distribution chart, ETHK Labs ranks #115 out of 116 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, ETHK Labs has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ETHK Labs' Days Inventory compare to MCK and COR?
According to the Medical Distribution industry distribution chart, ETHK Labs ranks #115 out of 116 companies for Days Inventory. This places ETHK Labs in the lower half of its industry. The industry median Days Inventory is 57.50. ETHK Labs' value of 387.16 is 573.4% above this benchmark. Historically, ETHK Labs' own Days Inventory has ranged from 62.26 to 355.67 over the past decade. While the company's 10-year median is 100.71 vs. the industry median of 57.50, ETHK Labs has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Distribution company?
The median Days Inventory among Medical Distribution companies is 57.50, based on 116 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ETHK Labs's current Days Inventory of 387.16 is 573.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on ETHK Labs and its competitors. For the Medical Distribution industry, the median Days Inventory is 57.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ETHK Labs's current Days Inventory is 387.16, which is 284% above median its own 10-year median of 100.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ETHK Labs stock overvalued right now?
Based on GuruFocus' analysis, ETHK Labs (HKSE:01931) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.38, compared to a current price of HK$0.58 — trading 58% below its estimated fair value. The current Days Inventory is 387.16, which is 284% above median its 10-year median of 100.71 and 573.4% above the Medical Distribution industry median of 57.50. ETHK Labs' overall GF Score™ is 74/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For ETHK Labs (HKSE:01931), the current Days Inventory is 387.16 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ETHK Labs (HKSE:01931) Overvalued in 2026?
Based on GuruFocus' analysis, ETHK Labs stock appears to be undervalued.
The current stock price of HK$0.58 is trading 58% below its estimated GF Value™ of HK$1.38.
GuruFocus considers ETHK Labs to be Possible Value Trap.
Key valuation signals for HKSE:01931:
Days Inventory: 387.16 (284% above median its 10-year median of 100.71)
GF Value™: HK$1.38 vs. price of HK$0.58 (58% below fair value)
Industry Position: 573.4% above the Medical Distribution median (#115 of 116)
No single metric tells the full story. See the HKSE:01931 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ETHK Labs Inc is engaged in the distribution, after-sales service, and development of in-vitro diagnostic (IVD) products in China. The company operates through three business segments: Distribution Business, After-sales Services, and Self-branded Products Business. It distributes IVD analysers, reagents, and consumables to hospitals and healthcare institutions, provides maintenance and installation services for diagnostic equipment, and develops and sells self-branded IVD analysers and reagents. The company generates the majority of its revenue from Mainland China.
74GF Score
Get the complete analysis for HKSE:01931
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01931 has been successfully added to your 
